• 3
    Haplo
    Score
  • 0
    Triplo
    Score

Gene Facts External Data Attribution

HGNC Symbol
IQSEC2 (HGNC:29059) HGNC Entrez Ensembl OMIM UCSC Uniprot GeneReviews LOVD LSDB ClinVar
HGNC Name
IQ motif and Sec7 domain ArfGEF 2
Gene type
protein-coding gene
Locus type
gene with protein product
Previous symbols
MRX1, MRX78, MRX18
Alias symbols
KIAA0522, BRAG1, IQ-ArfGEF
%HI
26.16(Read more about the DECIPHER Haploinsufficiency Index)
pLI
1(Read more about gnomAD pLI score)
LOEUF
0.13(Read more about gnomAD LOEUF score)
Cytoband
Xp11.22
Genomic Coordinates
GRCh37/hg19: chrX:53262058-53350548 NCBI Ensembl UCSC
GRCh38/hg38: chrX:53225813-53321350 NCBI Ensembl UCSC
MANE Select Transcript
NM_001111125.3 ENST00000642864.1 (Read more about MANE Select)
MANE Plus Clinical Transcript(s)
NM_001243197.2 ENST00000639161.2 (Read more about MANE Plus Clinical)
Function
Is a guanine nucleotide exchange factor for the ARF GTP- binding proteins. {ECO:0000269|PubMed:26793055}. (Source: Uniprot)

Dosage Sensitivity Summary (Gene)

Dosage ID:
ISCA-37489
ClinGen Curation ID:
CCID:007330
Curation Status:
Complete
Issue Type:
Dosage Curation - Gene
Haploinsufficiency:
Sufficient Evidence for Haploinsufficiency (3)
Triplosensitivity:
No Evidence for Triplosensitivity (0)
Last Evaluated:
04/07/2020

Haploinsufficiency (HI) Score Details

HI Score:
3
HI Evidence Strength:
Sufficient Evidence for Haploinsufficiency (Disclaimer)
HI Disease:
  • intellectual disability, X-linked 1 Monarch
HI Evidence:
  • PUBMED: 20473311
    The paper by Shoubridge describes missense mutations in males with intellectual disability. "In addition to moderate to severe intellectual disability in all affected males, seizures, autistic traits, psychiatric problems and delayed early language skills were noted, although none of these additional phenotypes were consistent in all affected individuals in the families." The authors showed the mutations reduced the expression of the protein.
  • PUBMED: 21479374
    Morleo et al describe a female patient with a t(X;20) with a severe phenotype that included intellectual disability, infantile seizures, and developmental delay. The authors used BAC FISH to map the breakpoints and found the translocation disrupted IQSEC2, between exons 1 and 2 of the longest transcript, which may also disrupt 5' regulatory sequences for the shorter trasncripts.
  • PUBMED: 23674175
    The article by Mau-Them et al describes two de novo intragenic duplications and a nonsense mutation in males with severe syndromic ID characterised by "progressive postnatal microcephaly, absence of speech and midline stereotypic hand movements similar to those observed in Rett or variant Rett syndromes." This article also cites the Gandomi reference describing two males with similar features who both have de novo truncating mutations.
NOTE:

The loss-of-function and triplosensitivity ratings for genes on the X chromosome are made in the context of a male genome to account for the effects of hemizygous duplications or nullizygous deletions. In contrast, disruption of some genes on the X chromosome causes male lethality and the ratings of dosage sensitivity instead take into account the phenotype in female individuals. Factors that may affect the severity of phenotypes associated with X-linked disorders include the presence of variable copies of the X chromosome (i.e. 47,XXY or 45,X) and skewed X-inactivation in females.

Triplosensitivity (TS) Score Details

TS Score:
0
TS Evidence Strength:
No Evidence for Triplosensitivity (Disclaimer)
NOTE:

The loss-of-function and triplosensitivity ratings for genes on the X chromosome are made in the context of a male genome to account for the effects of hemizygous duplications or nullizygous deletions. In contrast, disruption of some genes on the X chromosome causes male lethality and the ratings of dosage sensitivity instead take into account the phenotype in female individuals. Factors that may affect the severity of phenotypes associated with X-linked disorders include the presence of variable copies of the X chromosome (i.e. 47,XXY or 45,X) and skewed X-inactivation in females.

Genomic View

Select assembly: (NC_000023.10) (NC_000023.11)